Effect of preterm premature rupture of membranes on neurodevelopmental outcome: follow up at two years of age.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 8534623)

Published in Br J Obstet Gynaecol on November 01, 1995

Authors

A Spinillo1, E Capuzzo, M Stronati, A Ometto, S Orcesi, E Fazzi

Author Affiliations

1: Department of Obstetrics and Gynaecology, IRCCS Policlinico San Matteo, Mondino, Pavia, Italy.

Articles by these authors

Cryptic deletions are a common finding in "balanced" reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet (2007) 2.21

Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology (2006) 2.11

Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency. Neurology (2010) 1.88

Interaction between fetal gender and risk factors for fetal growth retardation. Am J Obstet Gynecol (1994) 1.79

Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol (1997) 1.75

Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit. J Hosp Infect (2008) 1.70

Benign paroxysmal vertigo of childhood: a long-term follow-up. Cephalalgia (1994) 1.63

Aicardi-Goutieres syndrome: neuroradiologic findings and follow-up. AJNR Am J Neuroradiol (2009) 1.53

NPHP1 gene deletion is a rare cause of Joubert syndrome related disorders. J Med Genet (2005) 1.47

Early morbidity and neurodevelopmental outcome in low-birthweight infants born after third trimester bleeding. Am J Perinatol (1994) 1.42

A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve (2000) 1.30

Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis. J Med Genet (2008) 1.20

Effectiveness of pamidronate in severe neonatal hypercalcemia caused by subcutaneous fat necrosis: a case report. Eur J Pediatr (2008) 1.20

Risk for spontaneous preterm delivery by combined body mass index and gestational weight gain patterns. Acta Obstet Gynecol Scand (1998) 1.18

Therapies in Aicardi-Goutières syndrome. Clin Exp Immunol (2014) 1.07

Nephronophthisis type 1 deletion syndrome with neurological symptoms: prevalence and significance of the association. Kidney Int (2006) 1.06

Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J Matern Fetal Neonatal Med (2012) 1.06

Cyclic vomiting and recurrent abdominal pains as migraine or epileptic equivalents. Cephalalgia (1983) 1.01

Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study. Neuromuscul Disord (2006) 1.01

Body composition and energy expenditure in Duchenne muscular dystrophy. Eur J Clin Nutr (2003) 0.99

Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection. Eur J Clin Microbiol Infect Dis (2009) 0.97

Predictors of independent walking in children with spastic diplegia. J Child Neurol (2000) 0.96

Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies. Clin Vaccine Immunol (2009) 0.96

Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women. Genitourin Med (1994) 0.96

Transsynaptic degeneration of lateral geniculate bodies in blind children: in vivo MR demonstration. AJNR Am J Neuroradiol (1997) 0.96

Psychological aspects of migraine in childhood. Cephalalgia (1983) 0.95

The natural history of Aicardi-Goutières syndrome: follow-up of 11 Italian patients. Neurology (2005) 0.95

Aicardi-Goutieres syndrome. Br Med Bull (2009) 0.95

Human cytomegalovirus immediate-early messenger RNA in blood of pregnant women with primary infection and of congenitally infected newborns. J Infect Dis (2001) 0.95

Short-term effects of "botulinum toxin a" as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint. Funct Neurol (2002) 0.94

Pregnancies complicated by idiopathic intrauterine growth retardation. Severity of growth failure, neonatal morbidity and two-year infant neurodevelopmental outcome. J Reprod Med (1995) 0.93

Bone mineral changes during and after lactation. Obstet Gynecol (1999) 0.93

Measurement of skeletal muscle mass in Duchenne muscular dystrophy: use of 24-h creatinine excretion. Acta Diabetol (2003) 0.92

Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis. Am J Obstet Gynecol (1999) 0.90

Cerebral visual impairment in periventricular leukomalacia. Neuropediatrics (1998) 0.90

Cerebral visual impairment in periventricular leukomalacia: MR correlation. AJNR Am J Neuroradiol (1996) 0.90

Different maturation of neutrophil chemotaxis in term and preterm newborn infants. J Pediatr (1982) 0.90

Significance of low birthweight for gestational age among very preterm infants. Br J Obstet Gynaecol (1997) 0.89

Value of antenatal corticosteroid therapy in preterm birth. Early Hum Dev (1995) 0.89

The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study. Neuromuscul Disord (2007) 0.88

The impact of oral contraception on vulvovaginal candidiasis. Contraception (1995) 0.88

The effect of work activity in pregnancy on the risk of fetal growth retardation. Acta Obstet Gynecol Scand (1996) 0.87

Torulopsis glabrata vaginitis. Obstet Gynecol (1995) 0.87

Recovery of visual functions after early acquired occipital damage. Dev Med Child Neurol (2008) 0.87

Meconium-stained amniotic fluid and risk for cerebral palsy in preterm infants. Obstet Gynecol (1997) 0.87

Prevalence of tic disorders among primary school students in the city of Pavia, Italy. Arch Dis Child (2004) 0.86

Recent advances in prevention of sepsis in the premature neonates in NICU. Early Hum Dev (2011) 0.86

Expanding CEP290 mutational spectrum in ciliopathies. Am J Med Genet A (2009) 0.85

Cerebral and somatic rSO2 in sick preterm infants. J Matern Fetal Neonatal Med (2012) 0.85

The effect of work activity in pregnancy on the risk of severe preeclampsia. Aust N Z J Obstet Gynaecol (1995) 0.84

Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient. Lupus (2013) 0.83

Lactoferrin and prevention of late-onset sepsis in the pre-term neonates. Early Hum Dev (2010) 0.83

Factors potentiating the smoking-related risk of fetal growth retardation. Br J Obstet Gynaecol (1994) 0.83

COL4A1 mutations associated with a characteristic pattern of intracranial calcification. Neuropediatrics (2011) 0.83

Neurodevelopmental outcome in very low birth weight infants at 24 months and 5 to 7 years of age: changing diagnosis. Pediatr Neurol (1997) 0.83

Benign paroxysmal vertigo in childhood: a migraine equivalent. ORL J Otorhinolaryngol Relat Spec (1984) 0.82

Cerebral lesions in early prematurity: EEG prognostic value in the neonatal period. Brain Dev (1987) 0.82

Maternal high-risk factors and severity of growth deficit in small for gestational age infants. Early Hum Dev (1994) 0.81

Neurodevelopmental outcome at 5-7 years in preterm infants with periventricular leukomalacia. Neuropediatrics (1994) 0.81

Extracranial radiosurgery: immobilizing liver motion in dogs using high-frequency jet ventilation and total intravenous anesthesia. Int J Radiat Oncol Biol Phys (2001) 0.81

Obstetric risk factors for periventricular leukomalacia among preterm infants. Br J Obstet Gynaecol (1998) 0.80

Use and misuse of antibiotics in the neonatal intensive care unit. J Matern Fetal Neonatal Med (2012) 0.80

Two-year infant neurodevelopmental outcome after expectant management and indicated preterm delivery in hypertensive pregnancies. Acta Obstet Gynecol Scand (1994) 0.80

Case-control study of maternal blood group and severe pre-eclampsia. J Hum Hypertens (1995) 0.80

Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newborns. J Chemother (2007) 0.80

Inhibition of the de-myelinating properties of Aicardi-Goutières syndrome lymphocytes by cathepsin D silencing. Biochem Biophys Res Commun (2012) 0.80

Aicardi-Goutières syndrome presenting atypically as a sub-acute leukoencephalopathy. Eur J Paediatr Neurol (2008) 0.80

Fluconazole use and safety in the nursery. Early Hum Dev (2012) 0.80

Inhibition of neuroblastoma cell growth by TREX1-mutated human lymphocytes. Oncol Rep (2012) 0.79

Cigarette smoking in pregnancy and risk of pre-eclampsia. J Hum Hypertens (1994) 0.79

The Aicardi-Goutières syndrome. Molecular and clinical features of RNAse deficiency and microRNA overload. Mutat Res (2011) 0.79

Variation of B-type natriuretic peptide concentrations and intrauterine growth restriction: mother, fetus and newborn. J Biol Regul Homeost Agents (2012) 0.79

Pharmacokinetics of antifungal agents in neonates and young infants. Curr Med Chem (2012) 0.79

Neonatal stroke. Minerva Pediatr (2010) 0.78

Infant neurodevelopmental outcome in pregnancies complicated by gestational hypertension and intra-uterine growth retardation. J Perinat Med (1993) 0.78

Prenatal diagnosis of congenital anomalies. Images Paediatr Cardiol (2001) 0.78

Preeclampsia, preterm delivery and infant cerebral palsy. Eur J Obstet Gynecol Reprod Biol (1998) 0.78

Antenatal and delivery risk factors simultaneously associated with neonatal death and cerebral palsy in preterm infants. Early Hum Dev (1997) 0.78